| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 03/24/2004 | EP1399122A1 Two-phase roll-on cosmetic product |
| 03/24/2004 | EP1399120A1 Breath protection microcapsules |
| 03/24/2004 | CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 03/24/2004 | CN1142769C Personal cleansing compositions |
| 03/24/2004 | CN1142768C Personal cleansing compositions |
| 03/23/2004 | US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/23/2004 | US6710184 Crystalline solids of carvedilol and processes for their preparation |
| 03/23/2004 | US6710028 Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron |
| 03/23/2004 | US6709443 Nosebleed lip pack |
| 03/18/2004 | WO2004022003A2 Materials and methods for treatment of allergic diseases |
| 03/18/2004 | WO2004022000A2 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 03/18/2004 | WO2004021999A2 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | WO2004021998A2 Gaming device and method |
| 03/18/2004 | WO2004021995A2 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 03/18/2004 | WO2004021993A2 Modified asialo-interferons and uses thereof |
| 03/18/2004 | WO2004021989A2 Imidazolopyridines and methods of making and using the same |
| 03/18/2004 | WO2004021980A2 Compositions and methods for treating niddm and other conditions and disorders associated with ampk regulation |
| 03/18/2004 | WO2004021978A2 Antisense modulation of endothelial specific molecule 1 expression |
| 03/18/2004 | WO2004006851A3 Mycoplasma gallisepticum formulation |
| 03/18/2004 | WO2003102116A3 Oil-soluble pigment compositions |
| 03/18/2004 | WO2003084471A8 Compositions selective for adenosine diphosphate and methods of using same |
| 03/18/2004 | WO2003051272A3 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 03/18/2004 | WO2003047500A3 Vaccine and method for treatment of motor neurone diseases |
| 03/18/2004 | WO2003035009A3 Treatment of acute myeloid leukemia with indolinone compounds |
| 03/18/2004 | US20040054639 Method, routines and system for identification of imprints on dosage forms |
| 03/18/2004 | US20040053986 3,7-Diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 03/18/2004 | US20040053937 Pyrimidine compounds |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040053852 Preventing desensitization of receptors |
| 03/18/2004 | US20040053838 Measuring serum IGF-I and/or IGF-I binding protein levels after birth of patient to obtain IGF-I or IGF-I binding protein level and correlating said level with in utero baseline level based on gestational age matched mean levels |
| 03/18/2004 | US20040053408 Comprises anticoagulant/thrombolytic agent for selective dissolution of fibrin clots |
| 03/18/2004 | US20040053233 Identifying antagonist and/or agonist of neovascularization for treatment and prevention of cancer, reproductive, skin, visual and wound healing disorders |
| 03/18/2004 | US20040052879 Solvent extraction with methanol; isomerization; antitumor agents |
| 03/18/2004 | US20040052875 Method and perparations having effect against allergic symptoms |
| 03/18/2004 | US20040052870 Cyclooxygenase (COX-2) inhibitors; for treatment/prevention of inflammation; nutraceuticals; for treatment of nervous system disorders |
| 03/18/2004 | US20040052868 Plant extracts; saponins |
| 03/18/2004 | CA2497968A1 Imidazolopyridines and methods of making and using the same |
| 03/18/2004 | CA2497788A1 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | CA2497777A1 Modified asialo-interferons and uses thereof |
| 03/18/2004 | CA2497552A1 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 03/18/2004 | CA2496744A1 Gaming device and method |
| 03/17/2004 | EP1398027A1 Use of matrix metalloproteinase inhibitors for treating or preventing glomerulopathy |
| 03/17/2004 | EP1397360A1 Azaindoles |
| 03/17/2004 | EP1397133A1 Rapid onset formulation |
| 03/17/2004 | EP1397131A1 Compositions comprising nitrofurantoin and uva ursi |
| 03/17/2004 | EP1192154B1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | EP1137644B9 Benzofuran derivatives, their preparation and use |
| 03/17/2004 | EP1135391B1 Novel triazolo(4,5-d)pyrimidine compounds |
| 03/17/2004 | EP1135108B1 Method for producing agglomerates comprising a core-shell structure |
| 03/17/2004 | EP0891362B1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 03/17/2004 | CN1142175C Sulfurization for oestrogen mixture |
| 03/17/2004 | CN1142144C 4-phenyl pyridine derivatives |
| 03/16/2004 | US6706878 Spiroazabicyclic heterocyclic compounds |
| 03/16/2004 | US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/16/2004 | US6706288 Microparticles |
| 03/16/2004 | US6706281 Melt-extrusion multiparticulates |
| 03/16/2004 | CA2100709C Method and means for site directed therapy |
| 03/11/2004 | WO2004020014A2 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/11/2004 | WO2004019960A2 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 03/11/2004 | WO2004019893A2 Modulators of angiogenesis |
| 03/11/2004 | WO2004019890A2 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 03/11/2004 | WO2004019887A2 Nosebleed lip pack |
| 03/11/2004 | WO2004019886A2 Methods for up-regulating antigen expression in tumors |
| 03/11/2004 | WO2004019881A2 Hypocretin administration as a treatment for obesity |
| 03/11/2004 | WO2004019875A2 Non-invasive methods to identify agents for treating pain |
| 03/11/2004 | WO2004019860A2 Formulations of modified antibodies and methods of making the same |
| 03/11/2004 | WO2003057133A3 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 03/11/2004 | US20040049083 Arylpiperazines having activity at the serotonin 1A receptor |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048927 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid |
| 03/11/2004 | US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/11/2004 | US20040048903 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 03/11/2004 | US20040048846 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
| 03/11/2004 | US20040048780 Administering an agent which inhibits protein kinase A phosphorylation of a type 2 ryanodine receptor (RyR2); for treating a subject afflicted with exercise-induced or stress-induced cardiac arrhythmia |
| 03/11/2004 | US20040048659 Gaming device and method |
| 03/11/2004 | US20040047929 Method to enhance the immune system and used for the prevention and treatment of asthma |
| 03/11/2004 | US20040047896 Composition for improving age-related physiological deficits and increasing longevity |
| 03/11/2004 | US20040047809 An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter of |
| 03/11/2004 | US20040045479 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 03/11/2004 | CA2497161A1 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 03/11/2004 | CA2497151A1 Methods for up-regulating antigen expression in tumors |
| 03/11/2004 | CA2497086A1 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/10/2004 | EP1395271A1 Herbal compositions for the treatment of mucosal lesions |
| 03/10/2004 | EP1395232A2 Cosmetic composition for nails, free of phthalates, camphor and aromatic solvent |
| 03/10/2004 | CN1481387A Condensed purine derivatives as A1 adenosine receptor antagonists |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/09/2004 | US6703506 Amino acid ester containing azole antifungals |
| 03/09/2004 | US6703502 Spiroazo bicyclic heterocyclic |
| 03/09/2004 | US6703361 Method of treating or preventing Type 1 diabetes by oral administration of insulin |
| 03/09/2004 | US6703053 For therapy |
| 03/09/2004 | US6703052 Long chain monounsaturated alcohol mixtures |
| 03/04/2004 | WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | WO2004017922A2 Keto cannabinoids with therapeutic indications |
| 03/04/2004 | WO2004017921A2 Method for treating inflammatory bowel disease |
| 03/04/2004 | WO2004017918A2 Method of preparing dry powder inhalation compositions |
| 03/04/2004 | WO2004017917A2 Method for the prevention and/or treatment of atherosclerosis |
| 03/04/2004 | WO2004017916A2 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 03/04/2004 | WO2004017914A2 Inhalation composition |
| 03/04/2004 | WO2004017909A2 Methods of reducing ischemic injury |